rs10759932
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Two single-nucleotide polymorphisms showed nominally statistically significant associations with prostate cancer risk, with the strongest (rs10759932) associated with a 4-fold increased risk of disease (P = 0.006).
|
17301271 |
2007 |
rs11536891
|
|
|
0.010 |
GeneticVariation |
BEFREE |
To evaluate the association of TLR4 polymorphisms and the risk for PC in Korean men, we genotyped five single-nucleotide polymorphisms (SNPs) of the TRL4 gene (rs11536858, rs1927914, 1927911, rs11536891, and rs11536897) by PCR-restriction fragment length polymorphism from unrelated 157 PC patients and 143 age-matched controls.
|
19380025 |
2009 |
rs11536897
|
|
|
0.010 |
GeneticVariation |
BEFREE |
To evaluate the association of TLR4 polymorphisms and the risk for PC in Korean men, we genotyped five single-nucleotide polymorphisms (SNPs) of the TRL4 gene (rs11536858, rs1927914, 1927911, rs11536891, and rs11536897) by PCR-restriction fragment length polymorphism from unrelated 157 PC patients and 143 age-matched controls.
|
19380025 |
2009 |
rs1927911
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The rs1927911 SNP increased the risk of PC (adjusted odds ratio ORadj=2.73, 95% CI=1.54-4.87 for the TC genotype; ORadj=6.68, 95% CI=3.27-13.66 for the CC genotype).
|
19380025 |
2009 |
rs1927914
|
|
|
0.010 |
GeneticVariation |
BEFREE |
To evaluate the association of TLR4 polymorphisms and the risk for PC in Korean men, we genotyped five single-nucleotide polymorphisms (SNPs) of the TRL4 gene (rs11536858, rs1927914, 1927911, rs11536891, and rs11536897) by PCR-restriction fragment length polymorphism from unrelated 157 PC patients and 143 age-matched controls.
|
19380025 |
2009 |
rs4986791
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Thr399Ile also may be connected with gallbladder cancer, and both of these polymorphisms apparently have no impact on risk of prostate cancer.
|
21081146 |
2011 |
rs11536889
|
|
|
0.020 |
GeneticVariation |
BEFREE |
The statistical analysis revealed that one SNP at the 3'UTR (rs11536889) showed significant association with the risk of prostate cancer (P (corr) = 0.005, OR = 1.81).
|
21553150 |
2012 |
rs4986790
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Our results suggested that Asp299Gly represented a risk factor on cancers in digestive system (G allele versus A allele, OR=1.64, 95% CI: 1.02-2.64; GA+GG versus AA, OR=1.64, 95% CI: 1.00-2.71) but tend to have a protective effect on prostate cancer (GG versus AA, OR=0.37, 95% CI: 0.14-0.98; GG versus GA+AA, OR=0.37, 95% CI: 0.14-0.98).
|
22441122 |
2012 |
rs4986790
|
|
|
0.020 |
GeneticVariation |
BEFREE |
A non-significant suggestion of effect modification was observed by rs4986790 carrier status on the association between T. vaginalis serostatus and prostate cancer risk (p interaction = 0.07).
|
23179660 |
2013 |
rs11536889
|
|
|
0.020 |
GeneticVariation |
BEFREE |
These findings indicate that rs11536889 in TLR4 might be specifically associated with prostate cancer.
|
26782430 |
2015 |